Atomic Minerals Announces Closing of Non-Brokered LIFE Offering and Concurrent Private Placement of $2.2MDecember 09, 2025 3:30 PM EST | Source: Atomic Minerals Corp.Vancouver, British Columbia--(Newsfile Corp. - December 9, 2025) - Atomic Minerals Corporation (TSXV: ATOM) ("Atomic Minerals" or the "Company") is pleased to announce that it has closed its non-brokered private placement under the listed issuer financing exemption under Part 5A of National Instrument 45-106 - Prospectus Exemption ...

Core Viewpoint - Atomic Minerals Corporation is conducting a non-brokered private placement to raise up to $1.8 million through a LIFE Offering and a Concurrent Private Placement, aimed at funding uranium exploration projects in Saskatchewan and the U.S. [1][6] Group 1: Financing Details - The LIFE Offering consists of up to 12,000,000 units priced at $0.05 per unit, aiming for gross proceeds of up to $600,000 [1] - The Concurrent Private Placement will offer up to 24,000,000 units at the same price, targeting gross proceeds of up to $1,200,000 [1] - Each unit includes one common share and one-half of a common share purchase warrant, with warrants exercisable at $0.10 for 12 months [2] Group 2: Use of Proceeds - The net proceeds from both offerings will be utilized for exploration activities at uranium projects in Saskatchewan and the Colorado Plateau, as well as for general administrative expenses [6] Group 3: Shareholder Rights Plan - The company has adopted a shareholder rights plan effective October 14, 2025, to ensure fair treatment of all shareholders during unsolicited take-over bids [9][10] - The plan includes provisions for rights attached to shares that become exercisable if an acquiring person obtains 20% or more of the voting securities without complying with the plan [11] - The plan is subject to ratification by shareholders at the upcoming annual general meeting on November 21, 2025 [12] Group 4: Market Making Engagement - Atomic Minerals has engaged Independent Trading Group as a market maker to enhance liquidity and maintain a reasonable market for its shares [13] - The market-making agreement includes a monthly compensation of CAD$6,000 plus GST, with an initial term of one month [14]

Core Insights - Atomic Minerals Corporation has received approval for drilling up to 15 holes at the Harts Point Uranium Project in Utah, targeting uranium mineralization at depths exceeding 1,500 feet [1][2] - The drilling aims to define and trace uranium mineralization along strike, potentially identifying a belt similar to that found in Lisbon Valley [2] - Historical data indicates significant uranium production in the Lisbon Valley area, with over 80 million pounds of uranium oxide produced from 1948 to 1988 [3] Company Overview - Atomic Minerals Corp. is publicly listed on the TSX Venture Exchange under the symbol ATOM, focusing on exploration opportunities in underexplored regions with geological similarities to known uranium deposits [10][11] - The company’s portfolio includes uranium projects across North America, particularly in the Colorado Plateau and Athabasca Basin, which have historically produced significant amounts of uranium [11] Project Details - The Harts Point property spans 6,500 acres and is located 64 kilometers north of the only operational conventional uranium mill in the U.S. [9] - The project consists of 324 lode mining claims on BLM land, with the approved drilling program aimed at validating historical results and enhancing understanding of the uranium potential at the site [9][7]

Revenue Performance - Revenue for the three months ended September 30, 2025, was approximately $11,000, a decrease of 50% compared to $22,000 for the same period in 2024[78] - Revenue for the nine months ended September 30, 2025, was approximately $15,000, a decrease of 86.6% compared to $112,000 for the same period in 2024[78] Cost and Expenses - Cost of revenue for the three months ended September 30, 2025, was $128,000, significantly higher than $3,000 for the same period in 2024[79] - Operating expenses for the three months ended September 30, 2025, totaled approximately $5.7 million, an increase of 18.8% compared to $4.8 million for the same period in 2024[80] - Research and development expenses for the three months ended September 30, 2025, were approximately $3.3 million, an increase of 20% compared to $2.8 million for the same period in 2024[82] - General and administrative expenses for the three months ended September 30, 2025, were approximately $2.2 million, an increase of 19% compared to $1.8 million for the same period in 2024[84] - Selling and marketing expenses for the three months ended September 30, 2025, were approximately $207,000, a decrease of 17% compared to $248,000 for the same period in 2024[86] Cash Flow and Financial Position - Net cash used in operating activities for the nine months ended September 30, 2025, was approximately $11.6 million, resulting from a net loss of approximately $15.7 million[92] - As of September 30, 2025, the company had cash and cash equivalents of approximately $20.3 million and working capital of approximately $18.1 million[96] - The company believes its available working capital is sufficient to fund its forecasted working capital requirements for at least the next 12 months[99] Accounting and Risk Disclosures - No changes to critical accounting estimates from the Annual Report on Form 10-K for the year ended December 31, 2024[100] - No applicable quantitative and qualitative disclosure about market risk[101]

Core Insights - Atomera Incorporated (NASDAQ: ATOM) is focused on semiconductor materials and technology licensing but is currently facing significant financial challenges, as evidenced by its earnings per share (EPS) of -$0.17 for Q3 2025, which missed the estimated EPS of -$0.14 [1][6] - The company's revenue for the quarter was reported at $11,000, significantly below the estimated $100,000, highlighting ongoing financial hurdles despite operational successes [2][6] - Atomera's financial metrics indicate a high price-to-sales ratio of 2,088.14 and a negative price-to-earnings (P/E) ratio of -5.08, reflecting its unprofitable status and that the stock is trading at a premium relative to its sales [2][3][6] Financial Performance - The negative enterprise value to operating cash flow ratio of -5.74 and earnings yield of -19.67% further illustrate the company's financial difficulties [3][6] - Despite these challenges, Atomera maintains a low debt-to-equity ratio of 0.06, indicating a conservative approach to debt management [4] - The strong current ratio of 8.14 suggests that the company is well-positioned to meet its short-term liabilities, providing some financial stability amidst struggles [4] Strategic Initiatives - Atomera's strategic moves, such as hiring Wei Na as Vice President of Sales and forming partnerships, indicate potential for future growth [5][6] - The collaboration with STMicroelectronics has not progressed as expected but has provided valuable insights and market credibility, broadening interest in Atomera's MST technology [5][6]

Financial Data and Key Metrics Changes - The GAAP net loss for Q3 2025 was $5.6 million or $0.17 per share, compared to a net loss of $4.6 million or $0.17 per share in Q3 2024 [18] - GAAP operating expenses increased to $5.7 million from $4.8 million in Q3 2024, driven by higher R&D and G&A expenses [18][19] - Non-GAAP net loss was $4.4 million in Q3 2025, up from a loss of $3.9 million in Q3 2024, primarily due to increased R&D expenses [19] - Cash and cash equivalents as of September 30, 2025, were $20.3 million, down from $22 million as of June 30, 2025 [20] Business Line Data and Key Metrics Changes - The company processed a record number of wafers for customers in the last three months, indicating strong operational activity across various technology focus areas [9] - The focus on MST starting wafers is expected to accelerate revenue generation due to easier integration into existing production flows [10][11] Market Data and Key Metrics Changes - Customers are evaluating MST for power devices between 5 and 48 volts, indicating a broadening market interest [8] - The semiconductor industry is entering a new materials innovation cycle, with a focus on performance, reliability, and reduced variability [15][16] Company Strategy and Development Direction - The company aims to prioritize revenue potential by focusing on the fastest time to market, highest return on investment, and breakthrough long-term growth [10] - Strategic partnerships are being leveraged to advance engagements in gate-all-around logic, memory, and power [17] - The company is actively pursuing new breakthrough materials enabled by MST through commercial partnerships and university collaborations [13] Management's Comments on Operating Environment and Future Outlook - Management acknowledged the challenges of bringing new material technology to market but emphasized the validation achieved with STMicroelectronics [4][6] - The company remains optimistic about future engagements with other customers in the power market segment [8] - The new VP of Sales is expected to enhance sales growth and convert existing opportunities into licenses [16] Other Important Information - The company has filed fundamental patents for several new materials under development, which may lead to disruptive technology announcements in various fields [13] - The gallium nitride initiative is progressing, with device fabrication underway to demonstrate improved electrical performance [14] Q&A Session Summary Question: Can you elaborate on the situation with STMicroelectronics? - The transition from 200 mm to 300 mm wafers led to a loss of ability to validate the new implementation in time for STMicroelectronics' production schedule [28][29] Question: What are the benefits learned from the STMicroelectronics engagement? - The company can apply the architecture and techniques developed with STMicroelectronics to other customers in the power space, enhancing their offerings [35] Question: How many transformative customers are currently engaged? - The company is actively working with more than two transformative customers, with ongoing engagements across various segments [39][40] Question: What is the status of the large demo run mentioned previously? - Revenue from the large demo run is expected to contribute to Q4, but specific timing and customer details remain complex due to the iterative nature of the engagements [43][45] Question: What is the expected timeline for gate-all-around projects to enter production? - Most gate-all-around projects are still a few years out from production, but some may improve yield on current processes and enter production quickly [56][57] Question: Can you provide details on the partnership with Sandia National Labs? - The partnership involves shared costs for testing, with the goal of generating valuable RF data for marketing purposes [59]

Company Overview - Atomera Incorporated focuses on Mears Silicon Technology (MST®), a quantum-engineered material designed to enhance transistor performance in the semiconductor market[5,6] - The company operates with a high-leverage IP licensing business model and possesses a strong patent portfolio[6] - MST technology targets advanced nodes, DRAM, RF-SOI, and power applications[7] Financial Performance (Q3 2025) - Revenue for the three months ended September 30, 2025, was $11 thousand, compared to $22 thousand for the three months ended September 30, 2024[11] - Operating loss for the quarter was $(5,793) thousand, compared to $(4,800) thousand in the same period last year[11] - Net loss was $(5,573) thousand, or $(0.19) per share, compared to a net loss of $(4,595) thousand, or $(0.17) per share, in Q3 2024[11] - Adjusted EBITDA (Non-GAAP) was $(4,440) thousand, or $(0.14) per share[11] - Cash, equivalents, and short-term investments totaled $20,322 thousand as of September 30, 2025[11] Strategic Focus - The company aims to improve customer products through MST integration, benefiting both parties financially[12] - MST can be used in starting wafers for RFSOI, GaN, and Next Gen DRAM, offering easier integration and faster time to revenue[9] - MST also targets high-volume potential products like GAA Logic, DRAM, Power, and Flash memory, which involve longer integration but offer higher revenue potential[9]

Financial Performance - The company reported a net loss of $5.6 million, or $0.17 per share, for Q3 2025, compared to a net loss of $4.6 million, or $0.17 per share, in Q3 2024[4] - Adjusted EBITDA for Q3 2025 was a loss of $4.4 million, compared to a loss of $3.9 million in Q3 2024[4] - Cash, cash equivalents, and short-term investments decreased to $20.3 million as of September 30, 2025, down from $26.8 million as of December 31, 2024[5] - The company experienced a gross margin loss of $117,000 in Q3 2025, compared to a gross margin of $19,000 in Q3 2024[16] - Total operating expenses for Q3 2025 were $5.7 million, up from $4.8 million in Q3 2024[16] Operational Highlights - The company processed a record number of MST wafers for customers during the quarter[8] - Research and development expenses increased to $3.3 million in Q3 2025, compared to $2.8 million in Q3 2024[16] - The total number of shares outstanding was 31.5 million as of September 30, 2025[6] Strategic Initiatives - The company announced the hiring of Wei Na as Vice President of Sales to enhance customer engagement and accelerate licensing agreements[3] - The company emphasized the importance of its collaboration with STMicroelectronics for gaining technical insights and market credibility despite not progressing as hoped[3]

Core Insights - Premarket trading is showing notable activity with significant price movements indicating potential trading opportunities before the market opens [1] Premarket Gainers - Beyond Meat, Inc. (BYND) has seen a substantial increase of 85%, trading at $6.73 [3] - Krispy Kreme, Inc. (DNUT) is up 37%, currently priced at $5.09 [3] - Splash Beverage Group, Inc. (SBEV) has risen by 35%, trading at $2.63 [3] - Rani Therapeutics Holdings, Inc. (RANI) is up 25%, priced at $3.59 [3] - 1-800-FLOWERS.COM, Inc. (FLWS) has increased by 24%, trading at $6.41 [3] - Vicor Corporation (VICR) is up 20%, currently at $79.15 [3] - WORK Medical Technology Group LTD (WOK) has risen by 19%, trading at $4.69 [3] - Intuitive Surgical, Inc. (ISRG) is up 17%, priced at $541.58 [3] - Pegasystems Inc. (PEGA) has increased by 12%, trading at $64.25 [3] - Biodesix, Inc. (BDSX) is up 6%, currently at $7.26 [3] Premarket Losers - Atomera Incorporated (ATOM) has experienced a significant decline of 41%, trading at $2.47 [4] - rYojbaba Co., Ltd. (RYOJ) is down 25%, currently priced at $6.77 [4] - Charming Medical Limited (MCTA) has decreased by 22%, trading at $5.42 [4] - AlphaVest Acquisition Corp (ATMV) is down 21%, priced at $10.63 [4] - Minerva Neurosciences, Inc. (NERV) has seen a decline of 17%, trading at $5.29 [4] - Owlet, Inc. (OWLT) is down 15%, currently at $7.42 [4] - Newegg Commerce, Inc. (NEGG) has decreased by 14%, trading at $42.95 [4] - Aveanna Healthcare Holdings Inc. (AVAH) is down 11%, priced at $9.09 [4] - Terns Pharmaceuticals, Inc. (TERN) has seen a decline of 10%, trading at $7.25 [4] - Bgin Blockchain Limited (BGIN) is down 10%, currently at $4.45 [4]

Core Viewpoint - Atomera Incorporated plans to release its third quarter 2025 financial results on October 28, 2025, after market close, indicating ongoing transparency and communication with investors [1] Company Summary - Atomera is a semiconductor materials and technology licensing company, highlighting its focus on innovation within the semiconductor industry [1] - The company will host a live video Zoom webinar at 2:00 p.m. on the same day as the financial results release, providing an opportunity for stakeholders to engage directly [1]